DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tasosartan
Tasosartan
Supplementary Appendix 1. Search Strategy for the Systematic Review and Meta-Analysis
Role of the Central Renin‑Angiotensin System in Hypertension (Review)
Customs Tariff - Schedule
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Appendices: V Ervolgonderzoek Medicatieveiligheid
Beta Blocker and Blood Pressure Medication Guidelines
Significant Beneficial Effect of AT-1 Receptor Blockers (Sartans) in Stroke
(12) Patent Application Publication (10) Pub. No.: US 2005/0054731A1 Folli Et Al
Beta Blocker and Blood Pressure Medication Guidelines
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Adverse Effects of Combination Angiotensin II Receptor Blockers
Supplementary Information
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Statistical Analysis Plan: 20140254 Date: 07 January 2017 Page 24
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Top View
Clinical Pharmacokinetics of Angiotensin II (AT1) Receptor Blockers in Hypertension
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Download Surveillance Report [PDF · 1.1
Ang Iotensin II New Class
Appendix A: Search Strategies Number of Citations in () / After an Index Term Indicates That All Subheadings Were Selected
Pharmacotherapy for Hypertension in Adults Aged 18 to 59 Years (Review)
ABSTRACTS of Oral
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
An Application to Include Blood Pressure Lowering Drug Fixed Dose
Combinations of CRF Antagonists and Renin-Angiotensin System Inhibitors
Web References W1 Frei M, Küster L, Von Krosigk PG, Koch H, Küppers
The New Angiotensin II Receptor Antagonist, Irbesartan Pharmacokinetic and Pharmacodynamic Considerations Hans R
Human Fetal Malformations Associated with the Use of an Angiotensin II Receptor Antagonist: Case Report
A Multi-Objective Approach for Drug Repurposing in Preeclampsia
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Supplementary Appendix
An Update on Non-Peptide Angiotensin Receptor Antagonists and Related RAAS Modulators ⁎ G.K